PICU, ANDREEA LOREDANA

PICU, ANDREEA LOREDANA  

Dip. MEDICINA INTERNA (attivo dal 01/01/1900 al 30/04/2013)  

Mostra records
Risultati 1 - 20 di 26 (tempo di esecuzione: 0.021 secondi).
Titolo Data di pubblicazione Autore(i) File
BASAL AND STIMULATED GH SECRETION IN CUSHING’S SYNDROME: EFFECTS OF GHRELIN AND GHRH+ARGININE 2009 A. Picu; E. Marinazzo; F. Prodam; F. Broglio; S. Belcastro; G. Amaretti; R. Giordano; E. Ghigo; E. Arvat
COMPARISON BETWEEN CORTISOL AND DEXAMETHASONE NEGATIVE FEEDBACK ACTION IN HUMANS 2006 M. Baldi; R. Giordano; A. Picu; M. Balbo; L. Bonelli; R. Berardelli; E. Ghigo; E Arvat
COMPARISON BETWEEN ITT, METYRAPONE AND ACTH STIMULATION WITH HIGH, LOW AND VERY LOW DOSES FOR DIAGNOSIS OF SECONDARY HYPOADRENALISM 2006 A. Picu; R. Giordano ; L. Bonelli; M. Balbo; M. Pellegrino; R. Berardelli; G. Corneli; V. Gasco; A. Gariano; E. Arvat
CONVENTIONAL GLUCOCORTICOID REPLACEMENT THERAPY IN PATIENTS WITH ADDISON’S DISEASE: EFFECT ON METABOLIC AND BONE PARAMETERS 2006 M. Balbo; R. Giordano ; L. Bonelli; R. Berardelli; A. Picu; A. Benso; M. Barberis; E. Arvat
EFFECT OF FREE FATTY ACIDS ON ACTH AND CORTISOL SECRETION IN ANOREXIA NERVOSA 2004 A. Picu; L. Gianotti; R. Giordano; G. Abbate Daga; V. Mondelli; F. Lanfranco; G. Malfi; S. Fassino; E. Ghigo; E. Arvat
EFFECT OF PROLONGED TREATMENT WITH POTASSIUM CANRENOATE, A MR ANTAGONIST, ON BASAL AND STIMULATED HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS 2009 R. Berardelli; E. Marinazzo; E. Prats; A. Picu; R. Giordano; I. Karamouzis; E. Ghigo; E Arvat
EFFECTS OF CORTISTATIN-17 AND SOMATOSTATIN-14 ON ACTH AND CORTISOL HYPERSECRETION IN PATIENTS WITH CUSHING’S DISEASE 2006 A. Picu; R. Giordano; L. Bonelli; R. Berardelli; S. Grottoli; F. Broglio; E. Ghigo; E Arvat
EFFECTS OF GHRELIN ON HYPOTHALAMO-PITUITARY-ADRENAL AXIS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY 2008 A. Picu; R. Giordano; L. Bonelli; E. Marinazzo; R. Berardelli; M. Balbo; E. Ghigo; E. Arvat
EFFECTS OF GNRH-RECEPTOR BLOCKADE ON GONADAL AXIS IN WOMEN WITH FUNCTIONAL HYPOTHALAMIC AMENORRHEA 2007 R. Berardelli; L. Gianotti; L. Bonelli; A. Picu; M. Balbo; R. Giordano; E. Ghigo; E. Arvat
EVALUATION OF BASAL AND STIMULATED ACTIVITY OF THE HYPOTHALAMO-PITUITARY-ADRENAL (HPA) AXIS IN PATIENTS WITH PRIMARY HYPERALDOSTERONISM 2003 M. Pellegrino; R. Giordano; M. Baldi; A. Picu; M. Balbo; E. Oleandri; C. Pellissetto; P. Limone; E. Ghigo; E. Arvat
EVALUATION OF BASAL AND STIMULATED HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) ACTIVITY IN PRIMARY HYPERALDOSTERONISM 2004 M. Pellegrino; R. Giordano; M. Baldi; A. Picu; M. Balbo; L. Bonelli; C. Pellissetto; P. Limone; E. Ghigo; E. Arvat
GLUCOCORTICOID RECEPTOR POLYMORPHISMS AND METABOLIC-CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER REPLACEMENT THERAPY 2011 R. Giordano; S. Marzotti; R. Berardelli; I. Karamouzis; E. Marinazzo; A. Picu; D. Forno; D. Zinnà; D. Giachino; A. Falorni; E. Ghigo; E. Arvat
HYPERCORTISOLISM DUE TO CUSHING’S DISEASE IS ASSOCIATED TO DERANGED GHRELIN SECRETION AND ACTION 2005 R. Giordano; A. Picu; U. Pagotto; R. De Iasio; L. Bonelli; F. Prodam; F. Broglio; R. Pasquali; M. Maccario; E. Ghigo; E. Arvat
HYPOTHALAMO-PITUITARY-ADRENAL (HPA) AXIS SENSITIVITY TO THE NEGATIVE FEED-BACK ACTION OF CORTISOL IN HUMANS 2003 R. Giordano; M. Baldi; M. Pellegrino; F. Lanfranco; M. Balbo; A. Picu; A. Barberis; E. Ghigo; E. Arvat
HYPOTHALAMO-PITUITARY-ADRENAL HYPERACTIVITY IN HUMAN AGING IS FURTHER ENHANCED BY MINERALCORTICOID ANTAGONISTS 2005 M. Pellegrino; R. Giordano; M. Baldi; M. Bo; M. Vezzari; A. Picu; M. Balbo; L. Bonelli; E. Ghigo; E. Arvat
LONG-TERM MORPHOLOGICAL AND HORMONAL FOLLOW-UP IN A SERIES OF 124 ADRENAL INCIDENTALOMAS 2009 E. Marinazzo; R. Berardelli; A. Picu; G. Peraga; E. Ghigo; E. Arvat; R. Giordano
METABOLIC AND CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY BEFORE AND 1 YEAR AFTER DISEASE REMISSION 2010 A. Picu; E. Marinazzo; M. Balbo; R. Berardelli; I. Karamouzis; E. Ghigo; R. Giordano; E. Arvat
Muscle fiber conduction slowing is a sensitive marker of steroid myopathy in Cushing’s disease 2011 Motta G; Lanfranco F; Botter A; Baldi M; Giordano R; Picu A; Ghigo E; Arvat E; Minetto MA
NEUROENDOCRINE EFFECT OF CITALOPRAM, A SELECTIVE SEROTONIN RE-UPTAKE INHIBITOR (SSRI), IN ANOREXIA NERVOSA 2005 M. Baldi; A. Picu; V. Mondelli; G. Abbate Daga; R. Giordano; F. Lanfranco; R. Berardelli; M. Balbo; S. Fassino; E. Arvat; L. Gianotti
NEUROENDOCRINE EFFECTS OF CITALOPRAM, A SELECTIVE SEROTONIN RE-UPTAKE INHIBITOR (SSRI), DURING LIFESPAN IN HUMANS 2008 R. Berardelli; E. Margarito; F. Ghiggia; A. Picu; L. Bonelli; M. Balbo; R. Giordano; M. Bo; E. Ghigo; E. Arvat